zm 241385 has been researched along with n-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide in 1 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (n-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide) | Trials (n-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide) | Recent Studies (post-2010) (n-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 45 | 0 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, MA; Doumad, AB; Falck, JR; Li, J; Liclican, EL; Stier, CT; Wang, J | 1 |
1 other study(ies) available for zm 241385 and n-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide
| Article | Year |
|---|---|
Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive.
Topics: Adrenergic alpha-2 Receptor Antagonists; Amides; Animals; Blood Pressure; Drinking; Eicosanoids; Hydroxyeicosatetraenoic Acids; Hypertension, Renal; Male; Natriuresis; Oxidoreductases; Rats; Rats, Inbred Dahl; Receptors, Adrenergic, alpha-2; Sodium Chloride, Dietary; Triazines; Triazoles | 2009 |